Details About Generic Salt ::  Influenz

Main Medicine Class:: Vaccine, inactivated virus   

(in-flew-EN-zuh virus vaccine)

FluShield

Injection (purified split-virus): 15 mcg each: A/Panama/2007/99 (H3N2) (A/Moscow/10/99[H3N2]-like), A/New Caledonia/20/99 (H1N1)-like, and B/Hong Kong/330/2001-like per 0.5 mL.

Fluvirin

Injection (purified split-virus): 15 mcg each: A/Panama/2007/99 (H3N2) (A/Moscow/10/99[H3N2]-like), A/New Caledonia/20/99 (H1N1)-like, and B/Hong Kong/330/2001-like per 0.5 mL.

Fluzone

Injection (purified split-virus): 15 mcg each: A/Panama/2007/99 (H3N2) (A/Moscow/10/99[H3N2]-like), A/New Caledonia/20/99 (H1N1)-like, and B/Hong Kong/330/2001-like per 0.5 mL.

Fluviral

Fluviral S/F

Vaxigrip

Class: Vaccine, inactivated virus

Drugs Class ::

 Action Induces formation of specific antibodies that protect against those strains of virus from which vaccine is prepared or to closely related strains.

Indications for Drugs ::

 Indications Induction of active immunity against influenza A and B viruses corresponding to strains in current-year vaccine formula; prophylaxis for people at least 6 mo at increased risk of complications or exposure to influenza. Fluvirin is not indicated for children under 4 yr.

Drug Dose ::

 Route/Dosage

ADULTS AND CHILDREN AT LEAST 9 YR: IM 0.5 mL 1 dose. CHILDREN 3 TO 8 YR: IM 0.5 mL 1 dose; however, if previously unvaccinated, give 2 doses at least 1 mo apart, administering the second dose before December if possible. CHILDREN 6 TO 35 MO: IM 0.25 mL 1 dose; however, if previously unvaccinated, give 2 doses at least 1 mo apart, administering the second dose before December if possible.

Contraindication ::

 Contraindications Immediate hypersensitivity to product or other components; hypersensitivity to eggs or egg products; delayed immunization is recommended for people with active neurologic disorder characterized by changing neurologic findings; defer immunization during acute respiratory disease or other active infection or during acute febrile illness.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Lactation: Influenza vaccine does not affect the safety of breastfeeding for mothers or infants. Children: Safety and efficacy not established in children less than 6 mo. Safety and efficacy of Fluvirin in children less than 4 yr not established.

Drug Side Effects ::

 Adverse Reactions

Soreness at injection site; fever; malaise; myalgia; Guillain-Barré syndrome; immediate (probably allergic) reactions (eg, hives, angioedema, allergic asthma, systemic anaphylaxis) occur extremely rarely.

Drug Mode of Action ::  

 Action Induces formation of specific antibodies that protect against those strains of virus from which vaccine is prepared or to closely related strains.

Drug Interactions ::

 Interactions

Anticoagulants: As with other IM drugs, give with caution to patients receiving anticoagulant therapy. Immunosuppressant drugs (eg, high-dose corticosteroids), radiation therapy: May result in inadequate response to immunization. Pertussis vaccine: In order to attribute causality of adverse reactions, do not give influenza vaccine within 3 days of pertussis vaccination. Theophylline: Theophylline levels may be increased during first 24 hr following vaccination.

Drug Assesment ::

 Assessment/Interventions

• Obtain patient history, including drug history and any known allergies.
• Report skin reactions (eg, erythema, rash, induration) or unusual neurological symptoms (eg, paresthesias, paralysis, encephalopathies) to health care provider.
• Provide written record of immunization and any untoward effects.

Drug Storage/Management ::

 Administration/Storage

• Agitate vial before administration.
• Use deltoid muscle for adults and older children.
• Use anterolateral aspect of thigh for infants older than 6 mo and for young children.
• Have epinephrine 1:1000 readily available.
• Do not give IV.
• Do not give to infants younger than 6 mo.
• Do not give within 3 days of vaccination with pertussis vaccine.

Drug Notes ::

 Patient/Family Education

• Advise patient that soreness at injection site may occur for 1 to 2 days.
• Instruct patient to report fever, malaise, myalgia, weakness, or headache to health care provider.
• Remind patient that vaccine needs to be given yearly.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.